AI assistant
TransMedics Group, Inc. — Director's Dealing 2024
Feb 3, 2024
31201_dirs_2024-02-02_76f60188-d973-499b-bae3-e8be5c35173f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2024-02-01
Reporting Person: Gordon Stephen (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-01 | Common Stock | M | 8833 | $13.28 | Acquired | 21908 | Direct |
| 2024-02-01 | Common Stock | M | 3644 | $16.14 | Acquired | 25552 | Direct |
| 2024-02-01 | Common Stock | M | 2523 | $38.46 | Acquired | 28075 | Direct |
| 2024-02-01 | Common Stock | S | 15000 | $85.45 | Disposed | 13075 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-01 | Stock Option (Right to Buy) | $13.28 | M | 8833 | Disposed | 2032-02-22 | Common Stock (8833) | Direct |
| 2024-02-01 | Stock Option (Right to Buy) | $16.14 | M | 3644 | Disposed | 2030-02-27 | Common Stock (3644) | Direct |
| 2024-02-01 | Stock Option (Right to Buy) | $38.46 | M | 2523 | Disposed | 2031-02-24 | Common Stock (2523) | Direct |
Footnotes
F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023.
F2: Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F3: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026.
F4: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 27, 2024.
F5: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025.